Clinical Trials Browser

Phase 2 × Endometrial Adenocarcinoma × cediranib × Clear all

NCT01132820 2019-08-08

Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer

Phase 2 Completed

53 enrolled 11 charts

Endometrial Adenocarcinoma